These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18409751)

  • 21. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P; Lim FS; Han HH; Willems P
    Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
    Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
    Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proposed vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), Varicella (chickenpox), and measles, mumps, rubella (MMR) vaccines--CDC. Notice with comment period.
    Fed Regist; 1998 Sep; 63(171):47026-31. PubMed ID: 10182707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine.
    Vesikari T; Sadzot-Delvaux C; Rentier B; Gershon A
    Pediatr Infect Dis J; 2007 Jul; 26(7):632-8. PubMed ID: 17596807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality standard for assurance of measles immunity among health care workers. The Infectious Diseases Society of America.
    Krause PJ; Gross PA; Barrett TL; Dellinger EP; Martone WJ; McGowan JE; Sweet RL; Wenzel RP
    Infect Control Hosp Epidemiol; 1994 Mar; 15(3):193-9. PubMed ID: 8207178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality standard for assurance of measles immunity among health care workers. Infectious Diseases Society of America.
    Krause PJ; Gross PA; Barrett TL; Dellinger EP; Martone WJ; McGowan JE; Sweet RL; Wenzel RP
    Clin Infect Dis; 1994 Mar; 18(3):431-6. PubMed ID: 8011829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old.
    Gatchalian S; Tabora C; Bermal N; Leboulleux D; Desauziers E
    Am J Trop Med Hyg; 2004 Mar; 70(3):273-7. PubMed ID: 15031516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization of hospital personnel and other health care workers.
    Decker MD; Schaffner W
    Infect Dis Clin North Am; 1990 Jun; 4(2):211-21. PubMed ID: 2140581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varicella vaccination in a primary care pediatric practice.
    Meine EK; Bailey SR; Drucker RP; Clements DA; Walter E
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):608-9. PubMed ID: 9641722
    [No Abstract]   [Full Text] [Related]  

  • 32. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 33. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on universal childhood immunizations.
    Hamlin J; Senthilnathan S; Bernstein HH
    Curr Opin Pediatr; 2008 Aug; 20(4):483-9. PubMed ID: 18622208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children.
    Wu JF; Ni YH; Chen HL; Hsu HY; Lai HS; Chang MH
    Vaccine; 2009 May; 27(21):2812-5. PubMed ID: 19366583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Whether chicken pox or polio, mumps, measles or rubella. Patience and persistence are needed if vaccination programs are to succeed].
    Liese J
    MMW Fortschr Med; 2005 Feb; 147(8):30. PubMed ID: 18441562
    [No Abstract]   [Full Text] [Related]  

  • 37. [Susceptibility to measles and varicella in healthcare workers in a tertiary hospital in Catalonia].
    Fernández-Cano MI; Armadans L; Sulleiro E; Espuga M; Ferrer E; Martínez-Gómez X; Vaqué J; Campins M
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):184-8. PubMed ID: 22137370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the introduction of universal varicella vaccination in the Netherlands.
    Boot HJ; de Melker HE; Stolk EA; de Wit GA; Kimman TG
    Vaccine; 2006 Sep; 24(37-39):6288-99. PubMed ID: 16790302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMR vaccine coverage falls in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1999 Jan; 9(5):37. PubMed ID: 10073054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.